We will examine what leads to MMRV infections and the measures being taken in the UK to prevent these diseases.

GSK has provided funding used to purchase exhibition space and a sponsored speaker session. GSK has had no input into the content of the programme or the choice of speakers with the exception of clearly marked GSK sponsored sessions. This promotional symposium, organised and funded by GSK, is intended for UK healthcare professionals attending this event only. GSK products will be mentioned at this symposium.

Join this practical and interactive session focused on bringing the Shingles National Immunisation Programme to life in primary care. We’ll explore the real impact shingles can have on patients’ quality of life, highlight opportunities to improve uptake, and share insights on how to make the programme work effectively in practice. You’ll get a clear overview of eligibility, dosing, and key components alongside practical tips for clinic organisation and patient communication. Designed to be collaborative and thought-provoking, this session will give you the chance to reflect on your current approach, share experiences, and discover new ideas to help optimise delivery in your setting.

NP-GB-HZU-ABST-260001 | July 2026

Older adults bear a disproportionate burden of morbidity and mortality from vaccine-preventable disease, with influenza, RSV and shingles alone accounting for thousands of deaths in over-65s in the UK each year. Yet vaccination rates in this population remain inconsistent, and significant barriers persist. Drawing on clinical experience delivering RSV, shingles, influenza and COVID-19 vaccines in general practice, this session explores the practical, clinical and ethical challenges of vaccinating older adults. It will examine current evidence and guidance underpinning each vaccine, consider hesitancy and consent, and share strategies for improving uptake. Delegates will leave with actionable insights applicable to their own immunisation practice in primary and community care settings.

This promotional presentation has been organised and funded by CSL Seqirus.

September 2026 | GBR-NOPR-26-0028

This session will consider the role of vaccination in pregnancy. It will consider the vaccine programmes recommended for pregnant women in the UK. The session will discuss the Influenza, Pertussis, Respiratory Syncytial virus (RSV) vaccine programmes and the rationale for protecting the pregnant women, the unborn infant and newborn baby for the first few months of life.

Vaccine hesitancy has become significant public health challenge since COVID-19. In the UK, it is seen to impede the widespread acceptance of national immunisation programmes. Linked to concerns about safety, misinformation and a lack of trust in authorities, vaccine hesitancy has been found to be more prominent in some communities than in others. It can also vary by vaccine. This talk will look at the evidence of how to address vaccine hesitancy in your day-to-day practice and the effective interventions for creating vaccine acceptance.